MedPath

Rehabilitation for lessening the symptoms and improving the quality of life in patients with repeated vasovagal syncope

Phase 3
Conditions
Vasovagal Syncope.
Syncope and collapse
Registration Number
IRCT20180125038507N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

All ptients with 2 or more vasovagal syncope episodes during the last year

Exclusion Criteria

Patients with structural heart diseases
Patients with abnormal ECG
Patients with neurologic diseases
Pregnant or breastfeeding women
Patients who receive psychiatric medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of syncope and syncope symptoms. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: Direct observation and measurement.;Quality of life. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: SF36 Scale.;Anxiety and depression. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: HADS Sclae.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath